Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

88 projects found matching your search criteria :

  1. Crystallography of DNA repair enzymes as a tool to study substrate specifity and a mechanism of inhibition

    Call: HARMONIA 1 , Panel: NZ1

    Principal investigator: prof. Barbara Tudek

    Instytut Biochemii i Biofizyki PAN

  2. The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its...

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: dr hab. Paweł Maga

    Uniwersytet Jagielloński, Collegium Medicum

  3. NADPH oxidase genes expression in peripheral blood mononuclear cells (PBMC) in anti-TNF alpha-treated rheumatoid arthrit...

    Call: PRELUDIUM 16 , Panel: NZ5

    Principal investigator: Tomasz Wysocki

    Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. prof. dr hab. med. Eleonory Reicher

  4. Cellular mechanisms and effects in vivo of selective lactate dehydrogenase A inhibitors in experimental models of mesoth...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Ryszard Smoleński

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  5. Definition of targetable signaling pathways in chronic lymphocytic leukemia patients with rationale to novel therapy wit...

    Call: PRELUDIUM 16 , Panel: NZ5

    Principal investigator: Joanna Knap-Stępień

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

  6. Impact of Polycomb Complex PRC1 inhibition on autophagy process in endometrial and breast cancer cells

    Call: PRELUDIUM 16 , Panel: NZ5

    Principal investigator: Aleksandra Szustka

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  7. Dual action mode inhibitors of urease and their anti-virulent activity against Helicobacter pylori and Cryptococcus neof...

    Call: OPUS 16 , Panel: NZ6

    Principal investigator: prof. Artur Mucha

    Politechnika Wrocławska

  8. Studies on mechanisms of GABAergic plasticity in the interneurons and pyramidal cells in mouse hippocampus

    Call: OPUS 16 , Panel: NZ4

    Principal investigator: prof. Jerzy Mozrzymas

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

  9. The significance of cancer specific PFK-II (PFKFB3 and PFKFB4) isoenzymes inhibition in overcoming resistance to BRAF in...

    Call: PRELUDIUM 16 , Panel: NZ5

    Principal investigator: Sonia Trojan

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski

  10. Deciphering molecular mechanism of CDK8 kinase inhibitors action in acute myeloid leukemia

    Call: SONATA BIS 8 , Panel: NZ2

    Principal investigator: dr hab. Michał Mikula

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy

  11. Extreme language control: activation and inhibition as bilingual control mechanisms in conference interpreting

    Call: SONATA BIS 8 , Panel: HS2

    Principal investigator: dr hab. Agnieszka Chmiel

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Anglistyki

  12. Association of TXNDC5 and calreticulin with decreased ER stress, allowing resistant multiple myeloma cells to by-pass pr...

    Call: PRELUDIUM 15 , Panel: NZ5

    Principal investigator: Tadeusz Kubicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski

  13. Significance of the TNF, TNFR1, TNFR2, TRAF1, TRAF6 and TACE gene polymorphisms, clinical parameters and biomarkers for ...

    Call: OPUS 1 , Panel: NZ5

    Principal investigator: dr hab. Jerzy Świerkot

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

  14. BET Bromodomain Inhibitors and improvement of glioblastoma therapy

    Call: OPUS 14 , Panel: NZ5

    Principal investigator: prof. Witold Korytowski

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  15. Studies of alkylation mechanism of DNA oligomers using new Top I inhibitors from camptothecin family by physical organic...

    Call: OPUS 14 , Panel: ST4

    Principal investigator: prof. Lech Kozerski

    Narodowy Instytut Leków

  16. Molecular origins of mechanisms governing biological functions of enzymes with buried actives sites: substrate inhibitio...

    Call: SONATA BIS 7 , Panel: NZ1

    Principal investigator: dr hab. Jan Brezovsky

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  17. Molecular mechanism of action and therapeutic effect of 5-aza-2'-deoxycytidine and topoisomerase inhibitors combination ...

    Call: OPUS 13 , Panel: NZ5

    Principal investigator: dr hab. Wojciech Kałas

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  18. Proteomic analysis of myeloma plasma cells to determine proteins and pathways involved in acquired resistance to proteas...

    Call: OPUS 13 , Panel: NZ5

    Principal investigator: dr hab. Dominik Dytfeld

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski

  19. Optical and time-resolved spectroscopy for hypothesis veryfication of the conducting by mTS the reductive reaction with ...

    Call: PRELUDIUM 13 , Panel: NZ1

    Principal investigator: Małgorzata Prokopowicz

    Uniwersytet Warszawski, Wydział Fizyki

  20. Design of new small molecular regulators (inhibitors, activators) of the catalytic activity of adenylate kinases. Molecu...

    Call: OPUS 13 , Panel: ST4

    Principal investigator: dr Anna Kozakiewicz-Piekarz

    Uniwersytet Mikołaja Kopernika w Toruniu, Wydział Chemii

  21. Influence of nematode gender for inhibiting immunological response mechanism by dendritic cells in mice.

    Call: PRELUDIUM 13 , Panel: NZ6

    Principal investigator: Marta Maruszewska-Cheruiyot

    Uniwersytet Warszawski, Wydział Biologii

  22. CBR1-dependent metabolism and ABCB1-dependent effux of doxorubicin - search for a novel mechanism of reversing resistanc...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: Kamil Piska

    Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  23. Structural studies on inhibition mechanisms of enzymes belonging to USP family, which remove ubiquitin from eukaryotic p...

    Call: SONATINA 1 , Panel: NZ1

    Principal investigator: dr Marcin Ziemniak

    Uniwersytet Warszawski, Wydział Chemii

  24. Insights into biological activity and mechanism of action of novel styrylquinazoline derivatives as tyrosine kinase inhi...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Katarzyna Malarz

    Uniwersytet Śląski w Katowicach, Wydział Matematyki, Fizyki i Chemii

  25. Evaluation of primary and secondary molecular disorders determinig drug resistance from a group of proteasome inhibitors...

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: prof. Tadeusz Robak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  26. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the colorectal cancer treatment

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: prof. Adam Dziki

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  27. Molecular characteristic of quorum sensing inhibition by selected essential oils in Pseudomonas spp. isolated from foods

    Call: SONATA 12 , Panel: NZ9

    Principal investigator: dr hab. Kamila Myszka

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Nauk o Żywności i Żywieniu

  28. Serum PAD-activity: Risk Factor in Development and Novel Biomarker in Rheumatoid Arthritis

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: dr hab. Piotr Mydel

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  29. Identification of the mechanism of sensitization of human ovarian cancer cells to anticancer drugs by the DNA double str...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Anna Macieja

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  30. Precision medicine-guided synthetic lethality targeting DNA repair to eradicate solid tumors

    Call: HARMONIA 8 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Śliwiński

    UNIWERSYTET ŁÓDZKI, Wydział Biologii i Ochrony Środowiska

  31. Structure and function characterization of newly discovered unique inhibitors of proteases

    Call: OPUS 11 , Panel: NZ1

    Principal investigator: prof. Jan Potempa

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  32. Molecular aspects of interference with the thymidylate synthase-catalyzed reaction mechanism by the slow-binding inhibit...

    Call: OPUS 11 , Panel: NZ1

    Principal investigator: prof. Wojciech Rode

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

  33. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the primary open-angle glaucoma treatmen...

    Call: OPUS 11 , Panel: NZ5

    Principal investigator: prof. Ireneusz Majsterek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  34. Functional carbon based coatings on titanium substrate, modified by laser ablation designed for the integration with car...

    Call: PRELUDIUM 11 , Panel: ST8

    Principal investigator: Klaudia Trembecka-Wójciga

    Instytut Metalurgii i Inżynierii Materiałowej im. Aleksandra Krupkowskiego Polskiej Akademii Nauk

  35. Tick-borne encephalitis virus - search for mechanisms useful in treatment and prophylaxis.

    Call: SONATA 10 , Panel: NZ6

    Principal investigator: dr hab. Ewelina Król

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  36. Molecular mechanism of action of substances decreasing the synthesis of glycosaminoglycans in terms of their potential u...

    Call: OPUS 1 , Panel: NZ1

    Principal investigator: dr hab. Magdalena Gabig-Cimińska

    Uniwersytet Gdański, Wydział Biologii

  37. The role of cognitive inhibition in the involuntary mental time travel.A comprehensive investigation of involuntary auto...

    Call: SONATA 10 , Panel: HS6

    Principal investigator: dr Krystian Barzykowski

    Uniwersytet Jagielloński, Wydział Filozoficzny

  38. Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Zofia Bielecka

    Wojskowy Instytut Medyczny